Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-27

Clinical Trial Update: Ixekizumab Diabetes Intervention Trial (I-DIT) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ixekizumab in Type 1 Diabetes Mellitus (I-DIT) is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ixekizumab (ixekizumab)

Snippet

Sponsor: Göteborg University | Conditions: Type1 Diabetes Mellitus | Phase 2 | Status: ACTIVE_NOT_RECRUITING